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Abstract
We previously showed that quercetin expresses its antiatherogenic effects by up-regulating paraoxonase 1 (PON1) gene and high-density
lipoprotein's protective capacity against low-density lipoprotein oxidation. In an attempt to elucidate the mechanism of action of quercetin,
we have now determined the effects of quercetin on PON1 gene expression, activity, protein level, nuclear mature sterol regulatory element
binding protein 2 (SREBP2) level, and its translocation from the endoplasmic reticulum to nucleus and its interaction with PON1 promoter in
human HuH7 liver cells using real-time reverse transcriptase polymerase chain reaction, spectrophotometry, immunoblot, confocal
microscopy, and electrophoretic mobility shift assay techniques, respectively. Quercetin (20 μmol/L) treatment increased PON1 messenger
RNA by 75% (P b .02), with a concomitant 2-fold (P b .05) increase in PON1 activity accompanied by 60% (P b .01) increase in PON1
protein level. There was parallel to the 1.5- to 2.0-fold increase (P b .05) in mature SREBP2 in the cell nuclei that was verified by increased
immunolocalization of the mature SREBP2 (65-kd species) in the nuclei of quercetin-treated cells by confocal microscopy. Evaluation of the
binding of biotin-labeled sterol responsive element (SRE)–like element of the PON1 promoter to the nuclear extract from the 24-hour
quercetin (20 μmol/L)–treated HuH7 cells by electrophoretic mobility shift assay revealed that the SREBP2 specifically binds to the SRElike element that was abolished by prior incubation with anti-SREBP2 or significantly decreased by 200-fold molar excess of unlabeled SRElike sequence. Based on these results, we conclude that quercetin exhibits its antiatherogenic property by eliciting the translocation of the
mature SREBP2 from endoplasmic reticulum to the nucleus, where it binds to SRE-like sequence in the PON1 promoter and up-regulates
PON1 gene transcription and PON1 activity.
© 2010 Published by Elsevier Inc.

1. Introduction
Paraoxonase 1 (PON1) is a calcium-dependent phosphotriesterase tightly associated with high-density lipoprotein
particles [1,2]. Experimental evidences have shown that
PON1 functions as an antioxidative enzyme that inhibits the
oxidation of low-density lipoprotein (LDL) [3-5] that
prevents the development of atherosclerosis [6,7]. It also
hydrolyzes homocysteine thiolactone to homocysteine,
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which alters the proteins in the arterial wall [8]. Paraoxonase
1 knockout mice are more susceptible to atherosclerosis than
wild-type littermates, and clinical studies have linked the
PON1 to the prevention of cardiovascular disease [9,10].
Sterol regulatory element binding proteins (SREBPs) are
a new class of membrane-bound transcription factors that
modulate lipid homeostasis [11]. Currently, 3 types of
SREBPs exist, namely, SREBP1a, SREBP1c, and SREBP2.
Whereas SREBP1a and SREBP1c control fatty acid
pathway, SREBP2 regulates cholesterol biosynthetic pathway. Sterol regulatory element binding protein 1a and
SREBP2 are present in most cultured cell lines, whereas
SREBP1c and SREBP2 are present in liver and other tissues.

0026-0495/$ – see front matter © 2010 Published by Elsevier Inc.
doi:10.1016/j.metabol.2009.12.025
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Newly synthesized SREBP is inserted into the endoplasmic
reticulum (ER) as an inactive protein. When the cellular
cholesterol is low, SREBP is escorted into the Golgi by
SREBP cleavage activating protein where it is proteolytically cleaved by specific proteases S1P and S2P in a 2-step
process to yield the mature SREBP that is translocated into
the nucleus, where it activates transcription by binding to
specific sterol responsive elements (SREs) in the promoter/
enhancer regions of multiple target genes.
Recent studies have shown conflicting results with regard
to the action of statins and flavones in the regulation of
PON1 gene [12-14]. Thus, whereas simvastatin [12] and soy
isoflavones [13] have been reported to modulate PON1 gene
via SREBP2, Gouedard et al [14] reported the opposite
effects by statins. Subsequently, the same group [15] came to
the conclusion that polyphenols regulate PON1 expression
via the aryl hydrocarbon receptor. However, a more recent
study indicates that pomegranate polyphenols regulate
PON1 expression via peroxisome proliferator-activated
receptor–γ pathway [16].
Quercetin, a ubiquitous flavonoid present in fruits and
vegetables, reduces LDL oxidation [17,18] presumably
because of its free radical-scavenging property and has
beneficial effects with respect to cardiovascular disease and
certain cancers [19]. We have recently shown that quercetin
supplementation in rats up-regulates liver PON1 expression
with associated inhibition of LDL oxidation [20]. In the
present study, we have demonstrated in HuH7 cells that
quercetin up-regulates not only PON1 expression with
associated increased PON1 promoter activity in SREdependent manner, but also its protein content and activity
in a dose-dependent manner within 24 hours of exposure
accompanied by concomitant increase in the nuclear mature
SREBP2 that specifically binds to the SRE-like sequence in
the PON1 promoter.

2. Experimental procedures
2.1. HuH7 cell culture
The human HuH7 liver cell line (a gift from Dr Terence
Donohue and Dr Natalia Osna, University of Nebraska
Medical Center, Omaha, NE) was maintained at 37°C in an
atmosphere containing 5% CO2 and cultivated in Dulbecco
modified Eagle medium, which was supplemented with heat
inactivated 10% fetal bovine serum, 1% L-glutamine, and
1% penicillin/streptomycin. HuH7 cells were plated at 70%
confluence and incubated with 0 to 20 μmol/L quercetin in
0.1% (vol/vol) dimethyl sulfoxide (DMSO) for either 24 or
48 hours. The control cells were exposed to 0.1% (vol/vol)
DMSO solvent vehicle alone.
2.2. RNA isolation
Replicate cultures of HuH7 cells were incubated in the
absence and presence of 10 and 20 μmol/L quercetin under
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standard conditions for 48 hours. The total RNA was isolated
from cell cultures using the Tri-Reagent (Molecular
Research Center, Cincinnati, OH) following the manufacturer's instructions. Total RNA concentrations were measured by absorbance reading at 260 nm using SpectroMAX
190 (Molecular Devices, Sunnyvale, CA). The purity and
concentration of total RNA samples were examined by
determining the AB260B/AB280B ratio. Isolated RNA was
used immediately or stored at −80°C until use.
2.3. Real-time polymerase chain reaction
The method was essentially as described by us previously
[20]. Briefly, complementary DNA templates for use in realtime polymerase chain reaction (PCR) were synthesized
from 5 μg of total RNA by in vitro transcription in 20-μL
reaction containing 0.5 μg Oligo (dT), 10 μmol/L dNTPs,
and 1 μL of Superscript II reverse transcriptase (Invitrogen,
Carlsbad, CA) at 42°C for 50 minutes. Typical real-time
PCR reaction mixture included the same amount of
complementary DNA templates from RT, 10 pmol of each
primer, 25 μL iQ SYBR Green Supermix (Bio-Rad,
Hercules, CA), and sterile water in a reaction volume of 50
μL. The PCR conditions were as follows: 3 minutes at
95°C followed by 40 cycles at 95°C for 30 seconds, 55°C for
30 seconds, and 68°C for 1 minute. The primer pairs for
human PON1 are:
Forward primer: 5′-CTGCTGATTGGCACAGTGTT-3′
Reverse primer: 5′-GGGTCAGCATTCATTGTTCA-3′.
This primer pair was first tested by regular PCR to be
highly effective and specific for amplification. β-Actin
(Ambion) was used as the housekeeping gene. Relative
PON1 gene expression level was calculated by subtracting
the threshold cycle number (Ct) of the β-actin gene from the
Ct of PON1 and raising 2 to the power of this difference. Ct
value is defined as the number of PCR cycles at which the
fluorescent signal during the PCR reaches a fixed threshold
for each sample.
2.4. PON1 activity measurement
For experiments to measure the influence of quercetin on
PON1 activity, we used 5 × 106 cells in 75-cm2 flasks.
Replicate cultures of HuH7 cells were incubated in the
absence and presence of 10 and 20 μmol/L quercetin under
standard conditions for 48 hours. At the end of the incubation
period, the cells were washed, harvested, and homogenized
in 50 mmol/L glycine:NaOH buffer, pH 10.5. A suitable
aliquot of each lysate was incubated with 1 mmol/L
paraoxon in the presence of 2 mmol/L CaCl2 at 37°C for
15 minutes. The extent of 4-nitrophenol formed was
measured based on the extinction coefficient of 18 290
(mol/L)−1 cm−1 for 4-nitrophenol [5]. The PON1 activity is
expressed as nanomoles of paraoxon hydrolyzed per hour
per milligram cell lysate.
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2.5. Sodium dodecyl sulfate polyacrylamide gel
electrophoresis and Western blot analyses
HuH7 cells were incubated with 0.1% DMSO (vol/vol)
alone or indicated concentrations of quercetin for 24 and
48 hours, after which the total cell and nuclear fractions
were extracted by NE-PER Nuclear and Cytoplasmic
Extraction Reagent (Pierce, Rockford, IL) containing
protease inhibitors (Roche, Indianapolis, IN) according to
the manufacturer's protocol. The total cell extract was
electrophoretically resolved in 4% to 15% denaturing
polyacrylamide gel (PAGE) and immunoblotted using
antibodies against PON1 (Abcam, Cambridge, MA) and
actin (Santa Cruz Biotech, Santa Cruz, CA). Similarly, the
nuclear extract was electrophoretically resolved by PAGE
and immunoblotted using antibodies against SREBP2 and
LaminB1 (Abcam). The proteins were visualized by
enhanced chemiluminescence using reagents from Perkin
Elmer (Waltham, MA), and the intensity of each band was
quantified using a Fluorchem 8800 densitometer (Alpha
Innotech, San Leandro, CA).

was used for these experiments (Biotin 3′ End DNA Labeling
Kit, Pierce). The binding reaction was carried out for 20 minutes
at room temperature in the presence of 50 ng/μL poly(dI-dC),
0.05% Nonidet P-40, 5 mmol/L MgCl2, 10 mmol/L EDTA, and
2.5% glycerol in 1× binding buffer (LightShift Chemiluminescent EMSA Kit, Pierce) using 20 fmol of biotin-end-labeled
target DNA and 4 μg of the nuclear extract from 24-hour
quercetin (20 μmol/L)–treated cells. For competitive assays, the
nuclear extract was first incubated with either unlabeled SRElike element (4 pmol) or 3 μL of anti-SREBP2 antibody
(Abcam) before the binding reaction was carried out. The
reaction mixture was loaded onto the native 4% polyacrylamide
gel that was preelectrophoresed for 30 minutes in 0.5× Trisborate-EDTA (TBE) followed by electrophoresis for 60 minutes
at 100 V and then electrophoretically transferred onto a
positively charged nylon membrane (Hybond-N+) in 0.5×
TBE at 100 V for 30 minutes. The membrane was cross-linked
at 120 mJ/cm2. The DNA-protein complex was visualized with
horseradish peroxidase–conjugated streptavidin (LightShift
Chemiluminescent EMSA Kit, Pierce) according to the
manufacturer's instructions.

2.6. Immunohistochemistry for SREBP2 using
confocal microscope

2.8. Determination of PON1 polymorphism

HuH7 cells were grown in 2 chamber slides and treated
with and without 20 μmol/L quercetin for 24 hours. At
the end of the incubation period, the cells were washed in
1× phosphate-buffered saline (PBS) for 3 times followed
by fixation in 4% formaldehyde solution in 1× PBS (pH
7.4) for 15 minutes and then permeabilized with 4%
formaldehyde solution in 0.2% (vol/vol) Triton X-100 in
1× PBS (pH 7.4) for another 10 minutes. After blocking
with 10% (vol/vol) normal donkey serum in 1× PBS (pH
7.4) for 1 hour at RT, the cells were incubated overnight
(4°C) with primary rabbit anti–human-SREBP2 (Abcam,
at 1:100 dilution) antibody. A control chamber in each
slide was not treated with primary antibody to account for
background fluorescence. All the cells were then incubated for 1 hour with donkey anti-rabbit immunoglobulin G
Alexa 488 secondary antibody (all dilutions 1:200) in the
dark. The cells were then washed 3 times with PBS for 5
minutes in the dark and were incubated with TOPRO for
1 minute to label the cell nuclei, and then rinsed with 1×
PBS. The slides were then mounted with a cover glass
and analyzed using a confocal microscope equipped with
Nikon Eclipse TE300 inverted microscope (Bio-Rad Laser
Radiance 2000).

The genotyping of the HuH7 cell line with respect to
PON1 polymorphism was assessed according to the
methods of Humbert et al [21] and Garin et al [22]. Briefly,
the DNA was extracted from the cell line using the DNA
Purification Kit (Qiagen Science, MD). Allele-specific
primers described by Humbert et al [21] to encompass the
polymorphism affecting position 192 were used to amplify
the polymorphic region of the gene. The PCR contained
approximately 100 to 500 ng DNA template, 0.1 μmol/L of
each primer, 0.2 mmol/L of the 4 deoxynucleotide triphosphates (dNTPs), 1 unit of high-fidelity Taq DNA
polymerase, and 1.5 mmol/L MgCl2. The DNA was
amplified in a PCR machine for 30 to 35 cycles. The PCR
optimal temperature and times were as follows: denaturation
at 94°C for 1 minute, annealing at 61°C for 1 minute, and
extension at 68°C for 1 minute, with a final extension for 5
minutes. The nucleotide substitution corresponding to
position 192 (Gln→Arg) creates an Alwl restriction site.
Allele Q (glutamine) corresponded to a 99-bp fragment,
whereas allele R (arginine) corresponded to 65- and 34-bp
fragments. The PCR product was restriction digested using
Alwl (New England Biolabs, Beverly, MA) at 37°C for 3
hours. The digested products were analyzed on a 3.5%
agarose gel cast and run in 1× TBE buffer.

2.7. Electrophoretic mobility shift assay
Electrophoretic mobility shift assay (EMSA) was carried
out to quantify the binding of nuclear SREBP2 to SRE core
sequence 5′-ATCACCCCAC-3′ and SRE-like sequence 5′ATCAAGCTAC-3′ (−392 to −382 base pairs [bp]) present in
the 5′ promoter region of PON1 gene. A nonradioactive
method where the 3′ end of the probe was labeled with biotin

2.9. Statistical analysis
Data are presented as the mean ± SD. All the values in
various experimental groups were normalized such that the
mean of the control group was taken as 1. Statistical
significance was determined by analysis of variance
followed by Tukey test.
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3. Results
3.1. Effect of quercetin concentration on PON1 activity and
protein level
Initially, we genotyped the PON1 isoform in HuH7 cells
with respect to polymorphism at amino acid 192 because
alterations in this allele are known to affect PON1 activity
with paraoxon as the substrate [21]. Thus, the HuH7 cell line
we have used in this study was characterized to be the
RQ192 isoform (data not shown). We then tested the
concentration effect of quercetin on the cellular activity of
PON1 and its protein level. As shown in Fig. 1A, cellular
PON1 activity increased from basal activity in a dosedependent manner with increasing concentration of quercetin in the culture medium. Thus, the cellular PON 1 activity
was increased up to 2-fold (P b .05), with a concomitant 60%
(P b .01) increase in the cellular PON1 protein (Fig. 1B) at
20 μmol/L quercetin concentration.
3.2. Effect of quercetin on the PON1 gene expression
To investigate whether the increase in PON1 activity and
protective effect of PON1 caused by quercetin correlated with
a concomitant up-regulation of its gene, real-time reverse
transcriptase PCR was performed on total RNA samples
prepared from HuH7 cells treated for 48 hours without and
with increasing concentrations of quercetin. The results are
shown in Fig. 2. There was a progressive up-regulation of
PON1 messenger RNA (mRNA) expression with increasing
quercetin concentration. Thus, PON1 mRNA increased up to
75% (P b .02) at 20 μmol/L quercetin (Fig. 2).
3.3. Up-regulation of PON1 gene correlates with the
increase in the level of the mature SREBP2 in the nucleus
To test whether the action of quercetin in the upregulation of PON1 gene was mediated via a corresponding
increase in the active form of the transcription factor,
SREBP2, we determined the mature SREBP2 protein (65-kd
species) level in the nucleus of HuH7 cells as a function of
quercetin concentration in the incubation medium. As shown
in Fig. 3, incubation of HuH7 cells for 24 hours with
increasing concentration of quercetin resulted in a dosedependent 1.5-fold (P b .01) and 2.0-fold (P b .05) increase
in SREBP2 in the nuclear extracts as evidenced by Western
blot for the mature form of SREBP2.
3.4. Quercetin increases the translocation of SREBP2 from
ER to nucleus
To confirm the results in Fig. 3 above, we carried out the
immunostaining of the control and 24-hour quercetin–
treated HuH7 cells for SREBP2 along with TOPRO (for
staining the nuclei) and analyzed by confocal microscopy. It
is obvious from confocal images that the intensity of the
SREBP2 band was negligible in the nuclei of control HuH7
cells that were not exposed to quercetin (Fig. 4A), whereas

Fig. 1. A, Effect of quercetin concentrations on PON1 activity in HuH7 liver
cells. HuH7 cells were incubated with the solvent vehicle alone (DMSO,
0.1% vol/vol) or with 10 and 20 μmol/L of quercetin (10 and 20 μmol/L Q)
for 48 hours. The PON1 activity in the cells was measured as described in
“Experimental procedures.” Analyses were performed in triplicate, and each
bar represents the mean ± SD of 3 samples in each group. The P values of
statistical significance were at *P b .02 and **P b .05 levels. B, Effect of
quercetin concentrations on PON1 protein in HuH7 liver cells. The cell
extracts from the various groups were resolved on sodium dodecyl sulfate
PAGE, and anti-PON1 and anti–β-actin (housekeeping gene) were used to
quantify the PON1 and β-actin proteins by Western blots as described in
“Experimental procedures.”. The PON1 level was normalized to the β-actin
protein for each sample. Analyses were performed in triplicate, and each bar
represents the mean ± SD of 3 samples in each group. The P values of
statistical significance were at *P b .02 and **P b .01 levels.

the intensity of SREBP2 in the nuclei of cells exposed to
quercetin was dramatically increased (Fig. 4B).
3.5. Nuclear SREBP2 from HuH7 cells interact directly with
PON1 SRE-like sequences
In an attempt to conclusively prove that SREBP2 was
involved in the quercetin-mediated up-regulation of PON1
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Fig. 2. Effect of quercetin concentrations on PON1 mRNA expression in
HuH7 liver cells. The cells were incubated with the solvent vehicle DMSO
alone (0.1% vol/vol) or with indicated concentrations of quercetin for 48
hours. The RNA extracted from each set of cells was reverse transcribed and
used in the real-time PCR analyses of PON1 mRNA or β-actin mRNA using
gene-specific primers as described in “Experimental procedures.” The PON1
mRNA level was normalized to the level of the β-actin mRNA for each
sample. Analyses were performed in triplicate, and each bar represents the
mean ± SD of 3 samples in each group. The P values of statistical
significance were at *P b .05 and **P b .02 levels.

promoter and that this up-regulation was indeed SRE
dependent, we performed EMSA with the SRE-like element
5′-ATCAAGCTAC-3′ (−392 to −382 bp). The SRE core
element 5′-ATCACCCCAC-3′ was used as the positive
control. Binding assay was carried out by EMSA using the
nuclear extracts from 24-hour quercetin (20 μmol/L)–treated
HuH7 cells with biotin-labeled SRE-like element and biotinlabeled SRE core sequence. As shown in Fig. 5, the oligoprotein complex band (corresponding to the arrow) was
clearly observed with both SRE core sequence (lane 1) and
SRE-like sequence (lane 2). In contrast, when the nuclear
extract was first incubated with anti-SREBP2 antibody, the
oligo-protein complex band was completely abolished (lane
3), indicating that the protein that formed the oligo-protein
complex band with the core SRE or SRE-like sequences
indeed was SREBP2. Furthermore, when the same binding
assay was carried out with 200-fold molar excess of
unlabeled SRE-like sequence, the intensity of the DNAprotein complex band was enormously decreased (lane 4),
indicating that SREBP2 specifically interacted with core
SRE and SRE-like sequence on the PON1 promoter.

dependent manner in HuH7 cells fully supports this concept.
It should be pointed out that the HuH7 cells used in this study
have the RQ192 isoform of PON1 that is known to exhibit
moderate activity with respect to paraoxon as the substrate
[21]. However, we have previously shown that moderate
ethanol up-regulates PON1 activity regardless of whether it
is low- or high-activity allele [5]. It would be interesting to
test whether or not quercetin also up-regulates PON1 in
different liver cell lines having exclusively the specific
RR192 or QQ192 or RQ192 isoform.
The PON1 gene is reported to be regulated by Sp1 and
protein kinase C (PKC) α or ζ, which interacts with the
consensus Sp1 binding site in PON1 promoter −111 to
−95 bp upstream of transcription initiation site. Overexpression of Sp1 dramatically enhanced PON1 promoter
activity. However, overexpression of PKC significantly
reduced PON1 promoter activity [23].
Previously, statins have been reported to up-regulate
PON1 gene via the interaction of SREBP2 with Sp1 site [12].
In contrast, others reported opposite effects of statins on the
PON1 gene regulation [14], implying that the action of
statins in the regulation of PON1 gene may be controversial.
A subsequent report [15] further complicated the confusion
in PON1 gene regulation by implying that dietary polyphenols up-regulate PON1 gene expression via aryl
hydrocarbon receptor–dependent mechanism, whereas a
more recent study has implicated the role of peroxisome
proliferator-activated receptor–γ pathway in the regulation
of PON1 expression by pomegranate polyphenols [16].

4. Discussion
Quercetin, a polyphenol commonly found in fruits and
vegetables, has been proven to possess antioxidative
properties [17,18]; and we have recently demonstrated that
quercetin feeding in both rats and LDLR−/− mice upregulated liver PON1 gene and activity with concomitant
protective capacity of high-density lipoprotein against LDL
oxidation [20]. Our present study demonstrating that
quercetin significantly up-regulates PON1 activity, PON1
protein level, as well as PON1 mRNA expression in a dose-

Fig. 3. Effect of quercetin concentrations on nuclear mature form of
SREBP2 in HuH7 liver cells. Nuclear proteins from quercetin treated (24 h)
and control cells were resolved on sodium dodecyl sulfate PAGE, and antiSREBP2 and anti-LaminB1 (housekeeping gene) were used to quantify the
mature SREBP2 and LaminB1 by Western blots as described in
“Experimental procedures.” The SREBP2 level was normalized to the
level of LaminB1 for each sample. Analyses were performed in triplicate,
and each bar represents the mean ± SD of 3 samples in each group. The P
values of statistical significance were at *P b .01 and **P b .05 levels. CN
indicates control.
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Fig. 4. Nuclear translocation of mature SREBP2. HuH7 cells were incubated with the solvent vehicle alone (DMSO, 0.1% vol/vol) or with 20 μmol/L quercetin
for 24 hours, after which they were immunostained with anti-SREBP2 antibody and TOPRO to stain the nuclei and analyzed by confocal microscopy as
described in “Experimental procedures.” A, Confocal image of control cells. B, Confocal image of quercetin-treated cells.

Our data (Fig. 3) demonstrating corresponding increase in
nuclear SREBP2 in quercetin-exposed cells strongly support
the possibility that, besides the Sp1 and PKC interaction
mechanism, quercetin-mediated up-regulation of PON1
gene could also be exerted via SREBP2. The definitive
role of SREBP2 in the quercetin-induced up-regulation of
PON1 is confirmed by the corresponding translocation of
mature SREBP2 (65-kd fragment) into the nucleus from the
inactive 125-kd fragment in the ER by confocal microscopy
(Fig. 4). Interestingly, SREBP2 has been shown to be
involved in soy isoflavones-mediated up-regulation of LDL
receptor in HepG2 cells [13]. Work is currently in progress
to test whether quercetin is directly involved in this

translocation of SREBP2 from ER to nucleus or via
alteration in cellular cholesterol.
Sterol regulatory element binding protein 2 interacts with
sterol responsive/regulatory element (SRE) or E-box present
in the promoters of target genes to regulate their expression.
The 1.8-kilobase PON1 promoter sequence was systematically analyzed, and several SRE and E-box consensus
sequences sites were found in the promoter region. The fact
that quercetin-mediated up-regulation of PON1 mRNA
correlated very well with the corresponding increase in the
mature SREBP2 in the nuclear fraction of HuH7 cells strongly
supports the concept that the action of quercetin is mediated
through the mature SREBP2. That the mature SREBP2 binds
to PON1 promoter in an SRE-dependent manner and upregulates PON1 gene is strongly supported by our demonstration that mature SREBP2 from the nuclear extract binds to
SRE-like sequence in the PON1 promoter that is abolished by
anti-SREBP2 as well by excess SRE sequence (Fig. 5).
We therefore conclude that quercetin exhibits its
antiatherogenic property by eliciting the translocation of
the mature SREBP2 from ER to the nucleus, which binds to
SRE-like sequence in the PON1 promoter and up-regulates
PON1 gene transcription and PON1 activity.
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